Otrs AG
F:TR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Otrs AG
F:TR9
|
DE |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
IE |
|
Mt Malcolm Mines NL
ASX:M2M
|
AU |
|
Actual Experience PLC
LSE:ACT
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TR9's stock price target?
Not Available
TR9 doesn't have any price targets made by Wall Street professionals.
What is Otrs AG's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Otrs AG's revenue is
9%.
The projected
CAGR
for the next 5 years is
6%.